ALVOTECH |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.48 USD | -0.14% |
|
+6.94% | +54.37% |
| 04-30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
| 04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
Chart calendar Alvotech
f08.4olLYy3EPmYS-lywjeMup5AdHpUNTDvjxyVAATItexU.kMA4JkqeWA1wnznXxJRkl-puTPhVL3aZo0oNeFVAI3672y8rVZ5ZPHW4GQ~cd9db50d9aff1ec01e6c9411f5f1b20d
Upcoming events on Alvotech
Past events on Alvotech
| 03/04/2024 13:15 | Business Update Call |
| 22/03/2024 14:00 | Capital Markets Day |
| 21/03/2024 12:00 | Q4 2023 Earnings Call |
| 20/03/2024 20:15 | Q4 2023 Earnings Release |
| 29/11/2023 13:00 | Q3 2023 Earnings Call |
| 28/11/2023 21:15 | Q3 2023 Earnings Release |
| 15/11/2023 13:00 | Jefferies London Healthcare Conference |
| 18/09/2023 | Northland Capital Markets Institutional Investor Conference |
| 31/08/2023 13:00 | Q2 2023 Earnings Call |
| 30/08/2023 21:15 | Q2 2023 Earnings Release |
| 07/06/2023 21:30 | Jefferies Global Healthcare Conference |
| 06/06/2023 08:00 | Annual General Meeting |
| 22/05/2023 15:15 | Morgan Stanley Sustainable Finance Summit |
| 19/05/2023 13:00 | Q1 2023 Earnings Call |
| 19/05/2023 10:00 | Q1 2023 Earnings Release |
| 02/03/2023 13:00 | Q4 2022 Earnings Call |
| 01/03/2023 21:30 | Q4 2022 Earnings Release |
| 17/11/2022 10:25 | Jefferies London Healthcare Conference |
| 16/11/2022 13:00 | Q3 2022 Earnings Call |
| 14/11/2022 | Q3 2022 Earnings Release After hours |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 36,8 | 83,0 104 -20.49% | 93,4 133 -29.99% | 321 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -326 -212 -53.62% | -331 -271 -21.8% | 60,7 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -346 -260 -33.47% | -355 -254 -39.67% | -25,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -552 -375 -47.16% | -651 -346 -88.16% | -184 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -514 -313 -64.08% | -552 -271 -103.47% | -149 |
|
EPS USD | Released Forecast Spread | -12,3 | -2,60 -1,55 -67.68% | -2,43 -1,09 -123% | -0,60 |
| Announcement Date | 10/05/22 | 01/03/23 | 20/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q2 |
|---|---|---|
|
Net income Million USD | Released Forecast Spread | 189 |
|
EPS USD | Released Forecast Spread | 0,85 |
| Announcement Date | 30/08/23 |
More events
Past sector events for Alvotech
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALVO Stock
- ALVO Stock
- Calendar Alvotech
